Document is current
Any future updates will be listed below
-
Authors
Wu, Xiao
Uhlig, Johannes
Shuch, Brian M.
Uhlig, Annemarie
Kim, Hyun S. https://orcid.org/0000-0002-3077-9989
- License Information
-
More Information
Article History
Received: 14 February 2022
Revised: 12 August 2022
Accepted: 30 September 2022
First Online: 4 November 2022
Declarations
: Approval from the Institutional Review Board was not required as no patient-level data was utilized.
: The scientific guarantor of this publication is Hyun S. Kim, MD MHS.
: The author certifies that they have no affiliations with or involvement in any organization or entity with any financial interest in the subject matter or materials discussed in this manuscript. HSK has served on Advisory Boards for Boston Scientific, SIRTex, Genentech, Eisai, Amgen, and Bayer, and was supported of research device support from Galil and database from Flatiron Health. JU received speaker fees from Bayer Vital GmbH on a subject not related to the study at hand.
: One of the authors has significant statistical expertise.
: Not applicable—cost-effectiveness analysis
: This study was approved by our local Institutional Review Board and compliant with the Health Insurance Portability and Accountability Act.
: • cost-effectiveness analysis study
